Steven Frank - 13 Mar 2025 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role
Director
Signature
/s/ Steven Frank, by Donald P. Lehr, as attorney-in-fact
Issuer symbol
PGEN
Transactions as of
13 Mar 2025
Net transactions value
+$49,999
Form type
4
Filing time
17 Mar 2025, 18:28:37 UTC
Previous filing
18 Mar 2024
Next filing
06 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGEN Common Stock Award $49,999 +28,735 +2.8% $1.74 1,052,895 13 Mar 2025 Direct F1
transaction PGEN Common Stock Options Exercise +87,412 +8.3% 1,140,307 14 Mar 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGEN Restricted Stock Units Award $0 +71,839 $0.000000 71,839 13 Mar 2025 Common Stock 71,839 Direct F2, F3
transaction PGEN Restricted Stock Units Options Exercise $0 -87,412 -100% $0.000000 0 14 Mar 2025 Common Stock 87,412 Direct F2, F4
transaction PGEN Option to Purchase Common Stock (Right to Buy) Award $0 +83,517 $0.000000 83,517 13 Mar 2025 Common Stock 83,517 $1.74 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued to the reporting person in lieu of an annual retainer of $50,000.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
F3 The RSUs vest in full on March 13, 2026.
F4 The RSUs vested in full on March 14, 2025.